Cargando…
Validation of a Patient-Derived Xenograft Model for Cervical Cancer Based on Genomic and Phenotypic Characterization
SIMPLE SUMMARY: The rate of total tumor engraftment of patient-derived xenografts is 50% in cervical cancer. These cancers retain their histopathological characteristics. The gene mutations and expression patterns associated with carcinogenesis and infiltration and the expression levels of genes in...
Autores principales: | Miyamoto, Shunsuke, Tanaka, Tomohito, Hirosuna, Kensuke, Nishie, Ruri, Ueda, Shoko, Hashida, Sousuke, Terada, Shinichi, Konishi, Hiromi, Kogata, Yuhei, Taniguchi, Kohei, Komura, Kazumasa, Ohmichi, Masahide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221029/ https://www.ncbi.nlm.nih.gov/pubmed/35740635 http://dx.doi.org/10.3390/cancers14122969 |
Ejemplares similares
-
Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review
por: Tanaka, Tomohito, et al.
Publicado: (2021) -
Endometrial Cancer Patient-Derived Xenograft Models: A Systematic Review
por: Tanaka, Tomohito, et al.
Publicado: (2022) -
Comparison of Prognosis between Minimally Invasive and Abdominal Radical Hysterectomy for Patients with Early-Stage Cervical Cancer
por: Tanaka, Tomohito, et al.
Publicado: (2022) -
Cancer-Specific miRNAs Extracted from Tissue-Exudative Extracellular Vesicles in Ovarian Clear Cell Carcinoma
por: Maruoka, Hiroshi, et al.
Publicado: (2022) -
Lymphatic Complications Following Sentinel Node Biopsy or Pelvic Lymphadenectomy for Endometrial Cancer
por: Terada, Shinichi, et al.
Publicado: (2023)